Adam J. Rish, Samuel Henson, James K. Drennen, Carl A. Anderson
{"title":"Defining the Range of Calibration Burden: From Full Calibration to Calibration-Free","authors":"Adam J. Rish, Samuel Henson, James K. Drennen, Carl A. Anderson","doi":"10.1007/s12247-024-09839-5","DOIUrl":null,"url":null,"abstract":"<div><p>The expansion of spectroscopic process analytical technology (PAT) within the pharmaceutical industry requires chemometric models to enable spectral interpretation. However, calibration of chemometric models often require an intense time, material, and financial burden which may discourage PAT deployment. The advancement of modeling strategies that reduce this calibration burden necessitates consistent terminology for describing model inputs and overall calibration burden throughout chemometric literature. The goal of this article is to define levels of calibration burden by clarifying dataset classifications and model inputs during PAT method development. The scope of this work is specific to calibration of chemometric models incorporated in PAT methods. Harmonizing the language used in the field of chemometrics to describe calibration burden benefits both pharmaceutical manufacturers and regulatory agencies.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"19 3","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12247-024-09839-5.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-024-09839-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
The expansion of spectroscopic process analytical technology (PAT) within the pharmaceutical industry requires chemometric models to enable spectral interpretation. However, calibration of chemometric models often require an intense time, material, and financial burden which may discourage PAT deployment. The advancement of modeling strategies that reduce this calibration burden necessitates consistent terminology for describing model inputs and overall calibration burden throughout chemometric literature. The goal of this article is to define levels of calibration burden by clarifying dataset classifications and model inputs during PAT method development. The scope of this work is specific to calibration of chemometric models incorporated in PAT methods. Harmonizing the language used in the field of chemometrics to describe calibration burden benefits both pharmaceutical manufacturers and regulatory agencies.
光谱过程分析技术(PAT)在制药行业的推广需要化学计量模型来进行光谱解读。然而,化学计量模型的校准往往需要大量的时间、材料和资金,这可能会阻碍 PAT 的应用。要推进可减轻校准负担的建模策略,就必须在化学计量学文献中使用一致的术语来描述模型输入和总体校准负担。本文的目的是在 PAT 方法开发过程中,通过明确数据集分类和模型输入,界定校准负担的程度。这项工作的具体范围是校准 PAT 方法中的化学计量模型。统一化学计量学领域描述校准负担的语言对制药商和监管机构都有好处。
期刊介绍:
The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories:
Materials science,
Product design,
Process design, optimization, automation and control,
Facilities; Information management,
Regulatory policy and strategy,
Supply chain developments ,
Education and professional development,
Journal of Pharmaceutical Innovation publishes four issues a year.